Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Dectrekumab (Anti-IL-13) For research use only.
Not for use in humans.

Dectrekumab (Anti-IL-13)

Synonyms: QAX576

Dectrekumab (anti-IL-13) is a humanized monoclonal antibody that targets interleukin-13 (IL-13). It has the potential to be used in inflammation and immunology-related research. MW: 146.16 KD.

Dectrekumab (Anti-IL-13)

Purity & Quality Control

≥99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Dectrekumab (anti-IL-13) is a humanized monoclonal antibody that targets interleukin-13 (IL-13). It has the potential to be used in inflammation and immunology-related research. MW: 146.16 KD.

Product Details

CAS No. 1528523-94-5
Molecular Weight 146.16
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Dectrekumab (Anti-IL-13) | Dectrekumab (Anti-IL-13) supplier | purchase Dectrekumab (Anti-IL-13) | Dectrekumab (Anti-IL-13) cost | Dectrekumab (Anti-IL-13) manufacturer | order Dectrekumab (Anti-IL-13) | Dectrekumab (Anti-IL-13) distributor